EMEND IV

Google image searchProduct monograph

Active ingredient

fosaprepitant (fosaprepitant dimeglumine), 150 MG/VIAL

DIN: 02363356

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-DOSE VIAL

Schedule: Prescription

Company: MERCK CANADA INC

Date: 04-APR-2011

ATC:

• A04 — ANTIEMETICS AND ANTINAUSEANTS (ATC, ATC/DDD, )
• A04A — ANTIEMETICS AND ANTINAUSEANTS (ATC, ATC/DDD)
• A04AD — Other antiemetics (ATC, ATC/DDD)

External Links for Emend Iv

Search on Google

• Emend Iv side effects
• Emend Iv dosage
• fosaprepitant side effects
• fosaprepitant dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find emend iv photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.